Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 4 | Molecular Cancer

Figure 4

From: Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo

Figure 4

Cells with reduced CDC25B level are delayed in G2/M transition. Hep3B and Hep40 cells were transfected with siRNA2-CDC25B, siRNA-N or RNAiMAX for 48 hours. Cell cycle distribution was determined by flow cytometry. A. Representative set of histograms for transfected and control cells. B. Percentage of cells in G2 stage. Columns, mean of at least three independent experiments; bars, SD; P < 0.05 for siRNA2-CDC25B versus siRNA-N transfected cells.

Back to article page